Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1991712 | 0.92 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1HSD17B10KDM4E | |
| SCHEMBL17099814 | 0.83 | TDP1 (0.48) | ALDH1A1TSHRKDM4ETDP1 | |
| SCHEMBL4077044 | 0.81 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL31133905 | 0.81 | TDP1 (0.50) | ALDH1A1TSHRKDM4ETDP1 | |
| SCHEMBL28438296 | 0.79 | CYP2C9 (0.47) | ALDH1A1TSHRKDM4ETDP1SIGMAR1 | |
| SCHEMBL28331482 | 0.77 | CHRM2 (0.35) | — | |
| SCHEMBL627539 | 0.76 | ALDH1A1 (0.37) | ALDH1A1KDM4EHRH4SIGMAR1 | |
| SCHEMBL329403 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1HSD17B10KDM4E | |
| SCHEMBL10921556 | 0.76 | CHRM2 (0.52) | — | |
| Trimethylammonium SCHEMBL15015633 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 408 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617939-B2 | Functional ethylene and 1,3-diene copolymers | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2026-05-05 | — | — | US | claimed |
| EP-4031591-B1 | FUNCTIONAL ETHYLENE AND 1,3-DIENE COPOLYMERS | MICHELIN & CIE (FR) | 2026-04-29 | — | — | EP | claimed |
| US-12479936-B2 | Functional ethylene and 1,3-diene copolymers | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2025-11-25 | — | — | US | claimed |
| EP-3687652-B1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORP (US) | 2025-07-09 | — | — | EP | claimed |
| WO-2023178286-A1 | CHEMICAL MECHANICAL PLANARIZATION USING AMINO-POLYORGANOSILOXANE-COATED ABRASIVES | MERCK PATENT GMBH (DE) | 2023-09-21 | — | — | WO | claimed |
| EP-4031382-B1 | FUNCTIONAL ETHYLENE AND 1,3-DIENE COPOLYMERS | MICHELIN & CIE (FR) | 2023-09-06 | — | — | EP | claimed |
| US-20230013682-A1 | FUNCTIONAL ETHYLENE AND 1,3-DIENE COPOLYMERS | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2023-01-19 | — | — | US | claimed |
| US-20220411619-A1 | FUNCTIONAL ETHYLENE AND 1,3-DIENE COPOLYMERS | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2022-12-29 | — | — | US | claimed |
| EP-3635051-B1 | FUNCTIONAL ETHYLENE AND 1,3-BUTADIENE COPOLYMER | MICHELIN & CIE (FR) | 2021-11-17 | — | — | EP | claimed |
| US-11155656-B2 | Functional ethylene and 1,3-butadiene copolymer | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2021-10-26 | — | — | US | claimed |
| US-20200140587-A1 | FUNCTIONAL ETHYLENE AND 1,3-BUTADIENE COPOLYMER | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2020-05-07 | — | — | US | claimed |
| EP-3635051-A1 | FUNCTIONAL ETHYLENE AND 1,3-BUTADIENE COPOLYMER | Compagnie Générale des Etablissements Michelin (FR) | 2020-04-15 | — | — | EP | claimed |
| US-20190126241-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORPORATION | 2019-05-02 | — | — | US | claimed |
| WO-2018224774-A1 | FUNCTIONAL ETHYLENE AND 1,3-BUTADIENE COPOLYMER | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2018-12-13 | — | — | WO | claimed |
| US-20140338429-A1 | METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2014-11-20 | — | — | US | claimed |
| US-20130319086-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2013-12-05 | — | — | US | claimed |
| WO-2012166916-A1 | METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS | WATERS TECHNOLOGIES CORPORATION (US) | 2012-12-06 | — | — | WO | claimed |
| US-20120273404-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2012-11-01 | — | — | US | claimed |
| EP-2462188-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | Waters Technologies Corporation (US) | 2012-06-13 | — | — | EP | claimed |
| WO-2011017418-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2011-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120273404-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | SPECC1L, SAMM50, RAB5IF | ALDH1A1 963/4885TSHR 3344/4885DNM1 4701/4885 |
| US-12617939-B2 | Functional ethylene and 1,3-diene copolymers | TELO2, RIF1, SMCHD1 | ALDH1A1 2143/4885TSHR 522/4885DNM1 4691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.